Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raphael Mohr

Showing results (1-10 of 75) with videos related to

Pageof 8
Sort By:
Drug Research|November 17, 2021
Raphael Mohr, Frank Tacke
Liver International : Official Journal of the International Association for the Study of the Liver|November 28, 2018
How to reduce mortality of bacterascites-That is the questionRaphael Mohr, Philipp Lutz
Alimentary Pharmacology & Therapeutics|May 7, 2024
Letter: Presence of progression or absence of response? Alternative trial designs for immunotherapy of advanced hepatocellular carcinoma. Authors' replyRaphael Mohr, Frank Tacke, Christoph Roderburg
Journal of Hepatocellular Carcinoma|February 15, 2023
Preoperative Immunotherapy in Hepatocellular Carcinoma: Current State of the ArtAlena Laschtowitz, Christoph Roderburg, Frank Tacke, et al.
Journal of Translational Internal Medicine|October 16, 2020
Pulmonary Complications in Patients with Liver CirrhosisFabian Benz, Raphael Mohr, Frank Tacke, et al.
Current Opinion in HIV and AIDS|May 21, 2014
Liver fibrosis in HIV: which role does HIV itself, long-term drug toxicities and metabolic changes play?Jürgen K Rockstroh, Raphael Mohr, Georg Behrens, et al.
International Journal of Molecular Sciences|March 29, 2023
Serum CXCL5 Detects Early Hepatocellular Carcinoma and Indicates Tumor ProgressionAlena Laschtowitz, Joeri Lambrecht, Tobias Puengel, et al.
Cancer Medicine|May 10, 2023
Systemic treatment in patients with Child-Pugh B liver dysfunction and advanced hepatocellular carcinomaFrederico Costa, Bertram Wiedenmann, Christoph Roderburg, et al.
Frontiers in Immunology|May 24, 2021
<i>In Situ</i> Vaccination as a Strategy to Modulate the Immune Microenvironment of Hepatocellular CarcinomaIsabella Lurje, Wiebke Werner, Raphael Mohr, et al.
International Journal of Molecular Sciences|July 19, 2020
In Vivo Models for Cholangiocarcinoma-What Can We Learn for Human Disease?Raphael Mohr, Burcin Özdirik, Jana Knorr, et al.
Pageof 8

Showing results (1-10 of 75) with videos related to

Sort By:
Pageof 8
Drug Research|November 17, 2021
Raphael Mohr, Frank Tacke
Liver International : Official Journal of the International Association for the Study of the Liver|November 28, 2018
How to reduce mortality of bacterascites-That is the questionRaphael Mohr, Philipp Lutz
Alimentary Pharmacology & Therapeutics|May 7, 2024
Letter: Presence of progression or absence of response? Alternative trial designs for immunotherapy of advanced hepatocellular carcinoma. Authors' replyRaphael Mohr, Frank Tacke, Christoph Roderburg
Journal of Hepatocellular Carcinoma|February 15, 2023
Preoperative Immunotherapy in Hepatocellular Carcinoma: Current State of the ArtAlena Laschtowitz, Christoph Roderburg, Frank Tacke, et al.
Journal of Translational Internal Medicine|October 16, 2020
Pulmonary Complications in Patients with Liver CirrhosisFabian Benz, Raphael Mohr, Frank Tacke, et al.
Current Opinion in HIV and AIDS|May 21, 2014
Liver fibrosis in HIV: which role does HIV itself, long-term drug toxicities and metabolic changes play?Jürgen K Rockstroh, Raphael Mohr, Georg Behrens, et al.
International Journal of Molecular Sciences|March 29, 2023
Serum CXCL5 Detects Early Hepatocellular Carcinoma and Indicates Tumor ProgressionAlena Laschtowitz, Joeri Lambrecht, Tobias Puengel, et al.
Cancer Medicine|May 10, 2023
Systemic treatment in patients with Child-Pugh B liver dysfunction and advanced hepatocellular carcinomaFrederico Costa, Bertram Wiedenmann, Christoph Roderburg, et al.
Frontiers in Immunology|May 24, 2021
<i>In Situ</i> Vaccination as a Strategy to Modulate the Immune Microenvironment of Hepatocellular CarcinomaIsabella Lurje, Wiebke Werner, Raphael Mohr, et al.
International Journal of Molecular Sciences|July 19, 2020
In Vivo Models for Cholangiocarcinoma-What Can We Learn for Human Disease?Raphael Mohr, Burcin Özdirik, Jana Knorr, et al.
Pageof 8